Patanwala Asad E, Abu Sardaneh Arwa, Alffenaar Jan-Willem C, Choo Chui Lynn, Dey Alexandra L, Duffy Eamon J, Green Sarah E, Hills Thomas E, Howle Lisa M, Joseph Jessica A, Khuon Maxkirivan C, Koppen Cassandra S, Pang Francis, Park Jung Yeun, Parlicki Mark A, Shah Isha S, Tran Kylie, Tran Priscilla, Wills Mardi A, Xu Jessica H, Youssef Marian
Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Department of Pharmacy, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Ann Pharmacother. 2025 Apr;59(4):311-318. doi: 10.1177/10600280241271223. Epub 2024 Aug 27.
There is little known about antibiotic de-escalation (ADE) practices in the intensive care unit (ICU).
The objective was to determine the proportion of patients who received ADE within 24 hours of actionable cultures and identify predictors of timely ADE.
Multicenter cohort study in ICUs of 15 hospitals in Australia and New Zealand. Adult patients were included if they were started on broad-spectrum antibiotics within 24 hours of ICU admission. The ADE was defined as switching from a broad-spectrum agent to a narrower-spectrum agent or antibiotic cessation. The primary outcome was ADE within 24 hours of an actionable culture, where ADE was possible.
The 446 patients included in the study had a mean age of 63 ± 16 years, 60% were male, 32% were mechanically ventilated, and 19% were immunocompromised. Of these, 161 (36.1%) were not eligible for ADE and 37 (8.3%) for whom ADE within 24 hours of actionable culture could not be determined. In the remaining 248 patients, ADE occurred ≤24 hours in 60.5% (n = 150/248) after actionable cultures. In the multivariable logistic regression analysis, ADE was less likely to occur within 24 hours for patients with negative cultures (odds ratio [OR] = 0.48, 95% confidence interval [CI] = 0.25-0.92, = 0.03).
Timely ADE may not occur in 40% of patients in the ICU and is less likely to occur in patients with negative cultures. Timely ADE can be improved, and patients with negative cultures should be targeted as part of antimicrobial stewardship efforts.
关于重症监护病房(ICU)抗生素降阶梯治疗(ADE)的实践,人们了解甚少。
确定在可采取行动的培养结果后24小时内接受ADE治疗的患者比例,并确定及时进行ADE治疗的预测因素。
在澳大利亚和新西兰15家医院的ICU进行多中心队列研究。纳入在ICU入院后24小时内开始使用广谱抗生素的成年患者。ADE定义为从广谱药物转换为窄谱药物或停用抗生素。主要结局是在可采取行动的培养结果后24小时内进行ADE治疗,前提是有可能进行ADE治疗。
纳入研究的446例患者的平均年龄为63±16岁,60%为男性,32%接受机械通气,19%免疫功能低下。其中,161例(36.1%)不符合ADE治疗条件,37例(8.3%)无法确定在可采取行动的培养结果后24小时内是否进行了ADE治疗。在其余248例患者中,60.5%(n = 150/248)在可采取行动的培养结果后≤24小时内发生了ADE治疗。在多变量逻辑回归分析中,培养结果为阴性的患者在24小时内发生ADE治疗的可能性较小(比值比[OR] = 0.48,95%置信区间[CI] = 0.25 - 0.92,P = 0.03)。
ICU中40%的患者可能无法及时进行ADE治疗,培养结果为阴性的患者发生ADE治疗的可能性较小。及时进行ADE治疗的情况可以得到改善,培养结果为阴性的患者应作为抗菌药物管理工作的一部分予以关注。